Details

session_id
sess_SDA-2026-04-10-gap-pubmed-20260410-185251-10f6a211
round_number
4
agent_persona
persona-synthesizer
agent_backend
minimax:MiniMax-M2.7
action
synthesize
tokens_used
689
persona_id
persona-synthesizer
Raw fields (1)
content

```json
{
  "ranked_hypotheses": [
    {
      "rank": 1,
      "hypothesis_id": "H4",
      "title": "Cdk5 Phosphorylation of Synaptic Proteins as the Primary Mediator of Cognitive Decline",
      "theorist_confidence": 0.65,
      "skeptic_reassessment": 0.55,
      "composite_score": 0.60,
      "scoring": {
        "mechanistic_plausibility": 0.78,
        "evidence_strength": 0.65,
        "novelty": 0.72,
        "feasibility": 0.68,
        "therapeutic_potential": 0.75,
        "druggability": 0.52,
        "safety_profile": 0.48,
        "competitive_landscape": 0.85,
        "data_availability": 0.72,
        "reproducibility": 0.70
      },
      "evidence_for": [
        {"claim": "Cdk5 phosphorylates PSD-95 at Ser561, disrupting synaptic targeting and glutamatergic transmission", "pmid": "19279202"},
        {"claim": "Cdk5-mediated NR2B phosphorylation at Ser1116 increases NMDA receptor internalization and excitotoxicity", "pmid": "15142982"},
        {"claim": "Conditional Cdk5 knockout in forebrain neurons causes impaired spatial memory before tau pathology appears", "pmid": "16888024"},
        {"claim": "Cdk5 phosphorylates Synapsin-1, regulating synaptic vesicle mobilization", "pmid": "10618395"},
        {"claim": "Synaptic Cdk5 substrates (PSD-95, NR2B) are non-redundant targets with established roles in memory", "pmid": "19797614"}
      ],
      "evidence_against": [
        {"claim": "Many Cdk5 substrates (NMDA receptors, AMPA receptors) are also phosphorylated by other kinases like CaMKII, reducing specificity", "pmid": "11438544"},
        {"claim": "Cdk5-independent Aβ toxicity documented through JNK3 activation and caspase-12 pathways", "pmid": "11836528"},
        {"claim": "Conditional knockout approaches are confounded by developmental compensation mechanisms", "pmid": "11278588"},
        {"claim": "Synaptic deficits may occur through parallel pathways independent of Cdk5", "pmid": "17382203"}
      ],
      "drug_development_assessment": "HIGH potential if selective inhibitors can be developed; synapse-sparing approach addresses developmental toxicity concern. Compound 6 (Pfizer, Ki ~6 nM) represents best chemical matter but not progressed.",
      "knowledge_edges": [
        {"source": "CDK5", "relation": "phosphorylates", "target": "PSD-95", "pmid": "19279202"},
        {"source": "CDK5", "relation": "phosphorylates", "target": "NR2B", "pmid": "15142982"},
        {"source": "CDK5", "relation": "phosphorylates", "target": "Synapsin-1", "pmid": "10618395"},
        {"source": "CDK5", "relation": "regulates", "target": "glutamate_signaling", "pmid": "19797614"},
        {"source": "Cognitive_decline", "relation": "precedes", "target": "tangle_pathology", "pmid": "16888024"}

Voting as anonymous. Sign in to attribute your signals.

tokens

Replication

No replications yet

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.